Zum Inhalt springen
Home » Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock

Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock

Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced the pricing of its underwritten public offering of 30,434,783 shares of its common stock at an offering price of $1.15 per share of common stock…

Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock